TRAnexamic acid in hemorrhagic CESarean section (TRACES) randomized placebo controlled dose-ranging pharmacobiological ancillary trial: study protocol for a randomized controlled trial

Table 1 Pilot study patients clinical and biological profile

	Group NH (n = 10)	Group H + TA (n = 15)	p
Elective CS (%)	100	60
Delay incision - inclusion (min)	16 [3]	31 [16]	0.008
CS duration (min)	48 [10]	98 [45]	0.002
Maternal age (years)	30.8 [5, 5]	31.8 [4, 4]	0.62
Total numer of gestations	2.8 [2, 7]	2.7 [1, 6]	0.92
Parity	2.6 [1, 2]	2.6 [1, 2]	0.95
Gestational age (SA)	37.5 [2, 7]	36.7 [3, 3]	0.52
Fetal weight (g)	3155 [1054]	2673 [966]	0.26
Bleeding volume (mL)	308 [138]	1501 [592]	<0.0001

ISSN: 1745-6215